PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Tonifying kidney (TK) methods using core herbs (including T. chinensis) combined with routine treatment were superior to routine treatment alone in lowering systolic and diastolic blood pressure and blood lipids [PMID:36465462].
Extracts of Taxillus chinensis (Loranthi Ramus) were found to be potent inhibitors of SARS-CoV in vitro using Vero E6 cells [PMID:24716104].
Ethyl acetate extract of T. chinensis (JEA) has beneficial effects in treating hyperuricemic nephropathy, potentially by inhibiting xanthine oxidase (XOD) activity [PMID:40214159].
Quercetin, a major flavonoid from T. chinensis, exerted antiarthritic effects in a collagen-induced arthritis mouse model [PMID:34023442].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36482376 (2022) — Taxillus chinensis (DC.) Danser: a comprehensive review on botany, traditional uses, phytochemistry, pharmacology, and toxicology. · Chinese medicine
- 2.PMID: 35482027 (2022) — Chromosome-Level Genome Assembly of the Hemiparasitic Taxillus chinensis (DC.) Danser. · Genome biology and evolution
- 3.PMID: 34946763 (2021) — Metabolomics Study of Flavonoids of Taxilluschinensis on Different Hosts Using UPLC-ESI-MS/MS. · Molecules (Basel, Switzerland)
- 4.PMID: 31220703 (2019) — Identification and analysis of cardiac glycosides in Loranthaceae parasites Taxillus chinensis (DC.) Danser and Scurrula parasitica Linn. and their host Nerium indicum Mill. · Journal of pharmaceutical and biomedical analysis
- 5.PMID: 40214159